Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Aslan Pharmaceuticals Ltd. ADR
ASLN
$
3.52
20%
Thu March 18th, 2021
13:00
Analysis
ASLAN Pharmaceuticals: A Next-Generation Dupixent And Potential 5x Return In A Year
Seeking Alpha
Fri December 25th, 2020
17:00
Analysis
ASLAN Pharmaceuticals Ltd. (ASLN) Moves to Buy: Rationale Behind the Upgrade
Zacks
Mon November 16th, 2020
11:30
Analysis
ASLAN Pharmaceuticals (ASLN) Sees Hammer Chart Pattern: Time to Buy?
Zacks
Mon October 19th, 2020
14:05
Analysis
ASLAN Pharmaceuticals (ASLN) in Focus: Stock Moves 7% Higher
Zacks
Sun October 18th, 2020
18:53
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
Analysis
Digest
Week In Review: Curon Bio Acquires Rights To Lymphoma Drug In $150 Million Deal
Seeking Alpha
Mon July 13th, 2020
16:00
Rating
Analysis
ASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: Here's Why
Zacks
Thu June 25th, 2020
12:50
Analysis
ASLAN Pharmaceuticals (ASLN) Looks Good: Stock Adds 8.7% in Session
Zacks
Thu June 11th, 2020
16:00
Rating
Analysis
ASLAN Pharmaceuticals Ltd. (ASLN) Upgraded to Buy: Here's What You Should Know
Zacks
